Pathophysiology of glia in perinatal white matter injury

GLIA

Volumn 62, Issue 11, 2014, Pages 1790-1815

  Back, Stephen A ^a,b   Rosenberg, Paul A ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Hyperoxia; Hypoxia; Hypoxia ischemia; Myelin; Oligodendrocyte

Indexed keywords

ADENOSINE; CYTOKINE; GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; REACTIVE OXYGEN METABOLITE;

ASTROCYTE; AXONAL INJURY; BRAIN HYPOXIA; BRAIN INFECTION; BRAIN ISCHEMIA; CELL MATURATION; CEREBRAL PALSY; ENCEPHALITIS; GLIA; HISTOPATHOLOGY; HUMAN; HYPEROXIA; MOLECULAR MECHANICS; NERVE FIBER REGENERATION; NEURAL STEM CELL; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERINATAL PERIOD; PREMATURITY; REVIEW; SURVIVOR; TISSUE OXYGENATION; WHITE MATTER; WHITE MATTER INJURY; ANIMAL; LEUKOENCEPHALOPATHIES; METABOLISM; MYELIN SHEATH; PATHOLOGY; PHYSIOLOGY;

ANIMALS; HUMANS; LEUKOENCEPHALOPATHIES; MYELIN SHEATH; NEUROGLIA; OXIDATIVE STRESS; PREMATURE BIRTH; RECEPTORS, GLUTAMATE;

EID: 84904341162     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22658     Document Type: Review

References (343)

1. Aarnoudse-Moens CS, Weisglas-Kuperus N, van Goudoever JB, Oosterlaan J. 2009. Meta-analysis of neurobehavioral outcomes in very preterm and/or very low birth weight children. Pediatrics 124:717-728.
2. Agresti C, D'Urso D, Levi G. 1996. Reversible inhibitory effects of interferon-γ and tumor necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur J Neurosci 8:1106-1116.
3. Aguirre A, Dupree JL, Mangin JM, Gallo V. 2007. A functional role for EGFR signaling in myelination and remyelination. Nat Neurosci 10:990-1002.
4. Alix JJ, Fern R. 2009. Glutamate receptor-mediated ischemic injury of premyelinated central axons. Ann Neurol 66:682-693.
5. Alix JJ, Zammit C, Riddle A, Meshul CK, Back SA, Valentino M, Fern R. 2012. Central axons preparing to myelinate are highly sensitivity to ischemic injury. Ann Neurol 72:936-951.
6. Anderson C, Swanson RA. 2000. Astrocyte glutamate transport: Review of properties, regulation, and physiological functions. Glia 32:1-14.
7. Anderson PJ, De Luca CR, Hutchinson E, Spencer-Smith MM, Roberts G, Doyle LW. 2011. Attention problems in a representative sample of extremely preterm/extremely low birth weight children. Dev Neuropsychol 36:57-73.
8. Anderson PJ, Doyle LW. 2008. Cognitive and educational deficits in children born extremely preterm. Semin Perinatol 32:51-58.
9. Andiman SE, Haynes RL, Trachtenberg FL, Billiards SS, Folkerth RD, Volpe JJ, Kinney HC. 2010. The cerebral cortex overlying periventricular leukomalacia: Analysis of pyramidal neurons. Brain Pathol 20:803-814.
10. Arranz AM, Hussein A, Alix JJ, Perez-Cerda F, Allcock N, Matute C, Fern R. 2008. Functional glutamate transport in rodent optic nerve axons and glia. Glia 56:1353-1367.
11. Asher R, Perides G, Vanderhaeghen J, Bignami A. 1991. Extracellular matrix of central nervous system white matter: Demonstration of an hyaluronan-protein complex. J Neurosci Res 28:410-421.
12. Azim K, Butt AM. 2011. GSK3beta negatively regulates oligodendrocyte differentiation and myelination in vivo. Glia 59:540-553.
13. Back S, Kroenke C, Sherman L, Lawrence G, Gong X, Taber E, Sonnen J, Larson E, Montine T. 2011. White matter lesions defined by diffusion tensor imaging in older adults Ann Neurol 70:465-476.
14. Back SA, Craig A, Kayton R, Luo NL, Meshul C, Allcock N, Fern R. 2007. Hypoxia-Ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. J Cereb Blood Flow Metab 27:334-347.
15. Back SA, Craig A, Luo N, Ren J, Akundi R, Rebeiro I, Rivkees S. 2006. Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury. Ann Neurol 60:696-705.
16. Back SA, Gan X-D, Li Y, Rosenberg PA, Volpe JJ. 1998. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 18:6241-6253.
17. Back SA, Han BH, Luo NL, Chrichton CA, Tam J, Xanthoudakis S, Arvin KL, Holtzman DM. 2002a. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 22:455-463.
18. Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC. 2001. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 21:1302-1312.
19. Back SA, Luo NL, Borenstein NS, Volpe JJ, Kinney HC. 2002b. Arrested oligodendrocyte lineage progression during human cerebral white matter development: Dissociation between the timing of progenitor differentiation and myelinogenesis. J Neuropathol Exp Neurol 61:197-211.
20. Back SA, Luo NL, Mallinson RA, O'Malley JP, Wallen LD, Frei B, Morrow JD, Petito CK, Roberts CT, Jr, Murdoch GH, et al. 2005b. Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes. Ann Neurol 58:108-120.
21. Back SA, Riddle A, Hohimer AR. 2012 The instrumented fetal sheep as a model of cerebral white matter injury in the preterm infant. Neurotherapeutics 9:359-370.
22. Back SA, Tuohy T, Chen H, Wallingford N, Craig A, Struve J, Luo N, Banine F, Liu Y, Chang A et al. 2005a. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 9:966-972.
23. Back SA, Volpe JJ. 1997. Cellular and molecular pathogenesis of periventricular white matter injury. MRDD Res Rev 3:96-107.
24. Back SA. 2006. Perinatal white matter injury: The changing spectrum of pathology and emerging insights into pathogenetic mechanisms. Ment Retard Dev Disabil Res Rev 12:129-140.
25. Baker TL, McGinty DJ. 1977. Reversal of cardiopulmonary failure during active sleep in hypoxic kittens: Implications for sudden infant death. Science 198:419-421.
26. Ballabh P. 2010. Intraventricular hemorrhage in premature infants: Mechanism of disease. Pediatr Res 67:1-8.
27. Banker B, Larroche J. 1962. Periventricular leukomalacia of infancy. A form of neonatal anoxic encephalopathy. Arch Neurol 7:386-410.
28. Bannai S, Kitamura E. 1980. Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. J Biol Chem 255:2372-2376.
29. Barkovich AJ, Ali FA, Rowley HA, Bass N. 1998. Imaging patterns of neonatal hypoglycemia. AJNR Am J Neuroradiol 19:523-528.
30. Barres B, Schmid R, Sendnte M, Raff M. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283-295.
31. Barrett RD, Bennet L, Naylor A, George SA, Dean JM, Gunn AJ. 2012. Effect of cerebral hypothermia and asphyxia on the subventricular zone and white matter tracts in preterm fetal sheep. Brain Res 1469:35-42.
32. Bassan H, Gauvreau K, Newburger J, Tsuji M, Limperopoulous C, Soul JS, Walter G, Laussen P, Jonas R, du Plessis A. 2005. Identification of pressure passive cerebral perfusion and its mediators after infant cardiac surgery. Pediatr Res 57:35-41.
33. Baud O, Greene A, Li J, Wang H, Volpe JJ, Rosenberg PA. 2004a. Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes. J Neurosci 24:1531-1540.
34. Baud O, Haynes R, Wang H, Folkerth RD, Li J, Volpe J, Rosenberg PA. 2004b. Developmental up-regulation of MnSOD in rat oligodendrocytes confers protection against oxidative injury. Eur J Neurosci 19:2669-2681.
35. Bax M, Tydeman C, Flodmark O. 2006. Clinical and MRI correlates of cerebral palsy: The European Cerebral Palsy Study. JAMA 296:1602-1608.
36. Beaino G, Khoshnood B, Kaminski M, Pierrat V, Marret S, Matis J, Ledesert B, Thiriez G, Fresson J, Roze JC et al. 2010. Predictors of cerebral palsy in very preterm infants: The EPIPAGE prospective population-based cohort study. Dev Med Child Neurol 52:e119-e125.
37. Bemelmans A, Husson I, Mailet J, Kosofsky B, Gressens P. 2006. Lentiviral-mediated transfer of brain-derived neurotrophic factor is neuroprotective in a mouse model of neonatal excitotoxic damage. J Neurosci Res 83:50-60.
38. Bennet L, Tan S, Van den Heuij L, Derrick M, Groenendaal F, van Bel F, Juul S, Back SA, Northington F, Robertson NJ, et al. 2012. Cell therapy for neonatal hypoxia-ischemia and cerebral palsy. Ann Neurol 71:589-600.
39. Bezzi P, Gundersen V, Galbete J, Seifert G, Steinhäuse rC, Pilati E, Volterra A. 2004. Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate. Nat Neurosci 7:613-620.
40. Billiards S, Haynes R, Folkerth R, NS B, Trachtenberg F, Rowitch D, Ligon K, Volpe J, Kinney H. 2008. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol 18:153-163.
41. Blackburn M, Datta S, Kellems R. 1998. Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency. J Biol Chem 273:5093-5100.
42. Blackburn M, Wakamiya M, Caskey C, Kellems R. 1995. Tissue-specific rescue suggests that placental adenosine deaminase is important for fetal development in mice. J Biol Chem 270:23891-23894.
43. Blomgren K, Hagberg H. 2006. Free radicals, mitochondria, and hypoxia-ischemia in the developing brain. Free Radic Biol Med 40:388-397.
44. Bona E, Aden U, Fredholm B, Hagberg H. 1995. The effect of caffeine treatment on hypoxic-ischemic brain damage in the neonate. Pediatr Res 38:312-318.
45. Bona E, Aden U, Gilland E, Fredholm B, Hagberg H. 1997. Neonatal cerebral hypoxia-ischemia: The effects of adenosine receptor antagonists. Neuropharmacology 36:1327-1338.
46. Borges K, Ohlemeyer C, Trotter J, Kettenmann H. 1994. AMPA/Kainate receptor activation in murine oligodendrocyte precursor cells leads to activation of a cation conductance, calcium influx and blockade of delayed rectifying K+ channels. Neuroscience 63:135-149.
47. Brash AR. 1999. Lipoxygenases: Occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 274:23679-23682.
48. 2T-IsoP on oligodendrocyte progenitors. Free Radic Biol Med 37:358-366.
49. Brault S, Martinez-Bermudez AK, Roberts J II, Cui QL, Fragoso G, Hemdan S, Liu HN, Gobeil F Jr, Quiniou C, Kermorvant-Duchemin E, Lachance C, Almazan G, Varma DR, Chemtob S. 2004b. Cytotoxicity of the E(2)-isoprostane 15-E(2t)-IsoP on oligodendrocyte progenitors. Free Radic Biol Med 37:358-366.
50. Burns CM, Rutherford MA, Boardman JP, Cowan FM. 2008. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics 122:65-74.
51. Buser JR, Segovia KN, Dean JM, Nelson K, Beardsley D, Gong X, Luo NL, Ren J, Wan Y, Riddle A, McClure MM, Ji X, Derrick M, Hohimer AR, Back SA, Tan S. 2010. Timing of appearance of late oligodendrocyte progenitors coincides with enhanced susceptibility of preterm rabbit cerebral white matter to hypoxia-ischemia, J Cereb Blood Flow Metab 30:1053-1065.
52. Buser JR, Maire J, Riddle A, Gong X, Nguyen T, Nelson K, Luo NL, Ren J, Struve J, Sherman LS, et al. 2012. Arrested pre-oligodendrocyte maturation contributes to myelination failure in premature infants. Ann Neurol 71:93-109.
53. Cai J, Tuong CM, Gozal D. 2011 A neonatal mouse model of intermittent hypoxia associated with features of apnea in premature infants. Respir Physiol Neurobiol 178:210-217.
54. Cai Z, Pang Y, Lin S, Rhodes P. 2003. Differential roles of tumor necrosis factor-alpha and interleukin-1 beta in lipopolysaccharide-induced brain injury in the neonatal rat. Brain Res 975:37-47.
55. Cao Y, Gunn A, Bennet L, Wu D, George S, Gluckman PD, Shao X-M, Guan J. 2003. Insulin-like growth factor (IGF)-1 suppresses oligodendrocyte caspase-3 activation and increases glial proliferation after ischemia in near-term fetal sheep. J Cereb Blood Flow Metab 23:739-747.
56. Capdevila JH, Falck JR. 2002. Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases. Prostaglandins Other Lipid Mediat 68-69:325-344.
57. Castillo-Melendez M, Chow J, Walker D. 2004. Lipid peroxidation, caspase-3 immunoreactivity, and pyknosis in late-gestation fetal sheep brain after umbilical cord occlusion. Pediatr Res 55:864-871.
58. CDC CfDCaP. 2004. Economic costs associated with mental retardation, cerebral palsy, hearing loss and vision impairment--United States, 2003. MMWR Morb Mortal Wkly Rep 53:57-59.
59. Chau V, Poskitt KJ, McFadden DE, Bowen-Roberts T, Synnes A, Brant R, Sargent MA, Soulikias W, Miller SP. 2009. Effect of chorioamnionitis on brain development and injury in premature newborns. Ann Neurol 66:155-164.
60. Chavez-Valdez R, Martin LJ, Flock DL, Northington FJ. 2012. Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia. Neuroscience 219:192-203.
61. Chen W, Mahadomrongkul V, Berger UV, Bassan M, DeSilva T, Tanaka K, Irwin N, Aoki C, Rosenberg PA. 2004. The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons. J Neurosci 24:1136-1148.
62. Cheng Y, Deshmukh M, D'Costa A, Demaro J, Gidday J, Shah A, Sun Y, Jacquin M, Johnson E Jr, Holtzman D. 1998. Caspase inhibitor affords neuroprotection with delayed adminstration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 101:1992-1999.
63. Clapp J III, Peress N, Wesley M, Mann L. 1988. Brain damage after intermittent partial cord occlusion in the chronically instrumented fetal lamb. Am J Obstet Gynecol 159:504-509.
64. Clouchoux C, du Plessis AJ, Bouyssi-Kobar M, Tworetzky W, McElhinney DB, Brown DW, Gholipour A, Kudelski D, Warfield SK, McCarter RJ, Robertson RL Jr, Evans AC, Newburger JW, Limperopoulos C. 2012. Delayed Cortical Development in Fetuses with Complex Congenital Heart Disease. Cereb Cortex 23:2932-2943.
65. Constantinou JC, Adamson-Macedo EN, Mirmiran M, Fleisher BE. 2007. Movement, imaging and neurobehavioral assessment as predictors of cerebral palsy in preterm infants. J Perinatol 27:225-229.
66. Coyle JT, Puttfarcken P. 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695.
67. Craig A, Luo NL, Beardsley DJ, Wingate-Pearse N, Walker DW, Hohimer AR, Back SA. 2003. Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human. Exp Neurol 181:231-240.
68. Czeh M, Gressens P, Kaindl AM. 2011. The Yin and Yang of microglia. Dev Neurosci 33:199-209.
69. Danbolt NC. 2001. Glutamate uptake. Prog Neurobiol 65:1-105.
70. Dean J, McClendon E, Hansen K, Azimi-Zonooz A, Chen K, Riddle A, Gong X, Sharifnia E, Hagen M, Ahmad T, Leigland LA, Hohimer AR, Kroenke CD, Back SA. 2013. Prenatal cerebral ischemia disrupts MRI-defined cortical microstructure through disturbances in neuronal arborization. Sci Transl Med 5:101-111.
71. Dean J, Moravec M, Grafe M, Abend N, Ren J, Gong X, Volpe J, Jensen F, Hohimer A, Back S. 2011. Strain-specific differences in perinatal rodent oligodendrocyte lineage progression and its correlation with human. Dev Neurosci 33:251-260.
72. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J. 2008. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4:313-321.
73. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J. 2005. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1:112-119.
74. Degterev A, Maki JL, Yuan J. 2013. Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ 20:366.
75. Deguchi K, Oguchi K, Takashima S. 1997. Characteristic neuropathology of leukomalacia in extremely low birth weight infants. Pediatr Neurol 16:296-300.
76. Delobel-Ayoub M, Arnaud C, White-Koning M, Casper C, Pierrat V, Garel M, Burguet A, Roze JC, Matis J, Picaud JC, Kaminski M, Larroque B. 2009. Behavioral problems and cognitive performance at 5 years of age after very preterm birth: The EPIPAGE Study. Pediatrics 123:1485-1492.
77. Deng W, Rosenberg P, Volpe J, Jensen F. 2003. Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors. Proc Natl Acad Sci USA 100:6801-6806.
78. Derrick M, N.L . L, Bregman JC, Jilling T, Ji X, Fisher K, Gladson CL, Beardsley DJ, Murdoch GA, Back SA, Tan S. 2004. Preterm fetal hypoxia causes hypertonia and motor deficits in the neonatal rabbit: A model for human cerebral palsy? J Neurosci 24:24-34.
79. DeSilva TM, Borenstein NS, Volpe JJ, Kinney HC, Rosenberg PA. 2012. Expression of EAAT2 in neurons and protoplasmic astrocytes during human cortical development. J Comp Neurol 520:3912-3932.
80. DeSilva TM, Kabakov AY, Goldhoff PE, Volpe JJ, Rosenberg PA. 2009. Regulation of glutamate transport in developing rat oligodendrocytes. J Neurosci 29:7898-7908.
81. DeSilva TM, Kinney HC, Borenstein NS, Trachtenberg FL, Irwin N, Volpe JJ, Rosenberg PA. 2007. The glutamate transporter EAAT2 is transiently expressed in developing human cerebral white matter. J Comp Neurol 501:879-890.
82. Dicou E, Rangon C, Guimiot F, Spedding M, Gressens P. 2003. Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brain. Brain Res 970:221-225.
83. Dimitropoulos A, McQuillen PS, Sethi V, Moosa A, Chau V, Xu D, Brant R, Azakie A, Campbell A, Barkovich AJ, Poskitt KJ, Miller SP. 2013. Brain injury and development in newborns with critical congenital heart disease. Neurology 81:241-248.
84. Domercq M, Etxebarria E, Perez-Samartin A, Matute C. 2005. Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition.Glia 52:36-46.
85. Domercq M, Sanchez-Gomez M, Areso P, Matute C. 1999. Expression of glutamate transporters in rat optic nerve oligodendrocytes. Eur J Neurosci 11:2226-2236.
86. Domingues AM, Neugebauer KM, Fern R. 2011. Identification of four functional NR3B isoforms in the developing white matter reveals unexpected diversity among glutamate receptors. J Neurochem 117:449-460.
87. Domingues AM, Taylor M, Fern R. 2010. Glia as transmitter sources and sensors in health and disease. Neurochem Int 57:359-366.
88. Dommergues M-A, Patkai J, Renauld J-C, Evrard P, Gressens P. 2000. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 47:54-63.
89. Doyle L. 2012. Antenatal magnesium sulfate and neuroprotection. Curr Opin Pediatr 24:154-159.
90. Doyle LW, Cheong J, Hunt RW, Lee KJ, Thompson DK, Davis PG, Rees S, Anderson PJ, Inder TE. 2010. Caffeine and brain development in very preterm infants. Ann Neurol 68:734-742.
91. Drobyshevsky A, Derrick M, Prasad P, Ji X, Englof I, Tan S. 2007a. Fetal brain magnetic resonance imaging response acutely to hypoxia-ischemia predicts postnatal outcome. Ann Neurol 61:307-314.
92. Drobyshevsky A, Derrick M, Wyrwicz A, Ji X, Englof I, Ullman L, Zelaya M, Northington F, Tan S. 2007b. White matter injury correlates with hypertonia in an animal model of cerebral palsy. J Cereb Blood Flow Metab 27:270-281.
93. Drobyshevsky A, Luo K, Derrick M, Yu L, Du H, Prasad PV, Vasquez-Vivar J, Batinic-Haberle I, Tan S. 2012. Motor deficits are triggered by reperfusion-reoxygenation injury as diagnosed by MRI and by a mechanism involving oxidants. J Neurosci 32:5500-5509.
94. Drobyshevsky A, Song S-K, Gamkrelidze G, Wyrwicz A, Derrick M, Meng F, Li L, Ji X, Trommer D, Beardsley D, et al. 2005. Developmental changes in diffusion anisotropy coincide with immature oligodendrocyte progression and maturation of compound action potential. J Neurosci 25:5988-5997.
95. Druzhyna N, Hollensworth S, Kelley M, Wilson G, Ledoux S. 2003. Targeting human 8-oxoguanine glycosylase to mitochondria of oligodendroyctes protects against menadione-induced oxidative stress. Glia 42:370-378.
96. Dugas JC, Cuellar TL, Scholze A, Ason B, Ibrahim A, Emery B, Zamanian JL, Foo LC, McManus MT, Barres BA. 2010. Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination. Neuron 65:597-611.
97. Ellison V, Mocatta T, Winterbourn C, Darlow B, Volpe J, Inder T. 2005. The relationship of CSF and plasma cytokine levels to cerebral white matter injury in the premature newborn. Pediatr Res 57:282-286.
98. Emery B, Agalliu D, Cahoy JD, Watkins TA, Dugas JC, Mulinyawe SB, Ibrahim A, Ligon KL, Rowitch DH, Barres BA. 2009. Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell 138:172-185.
99. Fancy S, Harrington E, Yuen T, Silbereis J, Zhao C, Baranzini S, Bruce C, Otero J, Huang E, Nusse R, et al. 2011a. Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 14:1009-1016.
100. Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, Rowitch DH. 2009. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23:1571-1585.
101. Fancy SP, Chan JR, Baranzini SE, Franklin RJ, Rowitch DH. 2011b. Myelin regeneration: A recapitulation of development? Annu Rev Neurosci 34:21-43.
102. Fancy SP, Kotter MR, Harrington EP, Huang JK, Zhao C, Rowitch DH, Franklin RJ. 2010. Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol 225:18-23.
103. Farahani R, Kanaan A, Gavrialov O, Brunnert S, Douglas RM, Morcillo P, Haddad GG. 2008. Differential effects of chronic intermittent and chronic constant hypoxia on postnatal growth and development. Pediatr Pulmon 43:20-28.
104. Favrais G, van de Looij Y, Fleiss B, Ramanantsoa N, Bonnin P, Stoltenburg-Didinger G, Lacaud A, Saliba E, Dammann O, Gallego J, Sizonenko S, Hagberg H, Lelievre V, Gressens P. 2011. Systemic inflammation disrupts the developmental program of white matter. Ann Neurol 70:550-565.
105. Feigenson K, Reid M, See J, Crenshaw EB III, Grinspan JB. 2009. Wnt signaling is sufficient to perturb oligodendrocyte maturation. Mol Cell Neurosci 42:255-265.
106. Felling RJ, Snyder MJ, Romanko MJ, Rothstein RP, Ziegler AN, Yang Z, Givogri MI, Bongarzone ER, Levison SW. 2006. Neural stem/progenitor cells participate in the regenerative response to perinatal hypoxia/ischemia. J Neurosci 26:4359-4369.
107. Fern R, Davis P, Waxman S, Ransom B. 1998. Axon conduction and survival in CNS white matter during energy deprivation: A developmental study. J Neurophysiol 79:95-105.
108. Fern R, Möller T. 2000. Rapid ischemic cell death in immature oligodendrocytes: A fatal glutamate release feedback loop. J Neurosci 20:34-42.
109. Ferriero DM, Miller SP. 2010. Imaging selective vulnerability in the developing nervous system. J Anat 217:429-435.
110. Folkerth R, Haynes R, Borenstein NS, Volpe JJ, Kinney HC. 2004a. Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter. J Neuropathol Exp Neurol 63:990-999.
111. Folkerth R, Keefe R, Haynes R, Trachtenberg F, Volpe J, Kinney H. 2004b. Interferon-gamma expression in periventricular leukomalacia in the human brain. Brain Pathol 14:265-274.
112. Follet PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, Volpe JJ, Jensen FE. 2004. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: A protective role for topiramate. J Neurosci 24:4412-4420.
113. Follet PL, Rosenberg PA, Volpe JJ, Jensen FE. 2000. NBQX attenuates excitotoxic injury to the developing white matter. J Neurosci 20:9235-9241.
114. Fontaine RH, Olivier P, Massonneau V, Leroux P, Degos V, Lebon S, El Ghouzzi V, Lelievre V, Gressens P, Baud O. 2008. Vulnerability of white matter towards antenatal hypoxia is linked to a species-dependent regulation of glutamate receptor subunits. Proc Natl Acad Sci USA 105:16779-16784.
115. Fowlie P, Davis P. 2003. Prophylactic indomethacin for preterm infants: A systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 88:F464-F466.
116. 2-induced oligodendrocyte cell death: Role of glutathione, mitogen-activated protein kinases and caspase 3. J Neurochem 90:392-404.
117. Franklin RJM, Gallo V. 2014. The translational biology of remyelination: Past, present, and future. Glia 62:1905-1915.
118. Fraser M, Bennet L, Van Zijl PL, Mocatta TJ, Williams CE, Gluckman PD, Winterbourn CC, Gunn AJ. 2008. Extracellular amino acids and lipid peroxidation products in periventricular white matter during and after cerebral ischemia in preterm fetal sheep. J Neurochem 105:2214-2223.
119. French HM, Reid M, Mamontov P, Simmons RA, Grinspan JB. 2009. Oxidative stress disrupts oligodendrocyte maturation. J Neurosci Res 87:3076-3087.
120. Galli K, Zimmerman R, Jarvik G, Wernovsky G, Kuypers M, Clancy R, Montenegro L, Mahle W, Newman M, Saunders A, Nicolson SC, Spray TL, Gaynor JW. 2004. Periventricular leukomalacia is common after neonatal cardiac surgery. J Thorac Cardiovasc Surg 127:692-704.
121. George SA, Barrett RD, Bennet L, Mathai S, Jensen EC, Gunn AJ. 2012. Nonadditive neuroprotection with early glutamate receptor blockade and delayed hypothermia after asphyxia in preterm fetal sheep. Stroke 43:3114-117.
122. Gerstner B, Buhrer C, Rheinlander C, Polley O, Schuller A, Berns M, Obladen M, Felderhoff-Mueser U. 2006. Maturation-dependent oligodendrocyte apoptosis caused by hyperoxia. J Neurosci Res 84:306-315.
123. Gerstner B, DeSilva TM, Genz K, Armstrong A, Brehmer F, Neve RL, Felderhoff-Mueser U, Volpe JJ, Rosenberg PA. 2008. Hyperoxia causes maturation-dependent cell death in the developing white matter. J Neurosci 28:1236-1245.
124. Gerstner B, Sifringer M, Dzietko M, Schuller A, Lee J, Simons S, Obladen M, Volpe JJ, Rosenberg PA, Felderhoff-Mueser U. 2007. Estradiol attenuates hyperoxia-induced cell death in the developing white matter. Ann Neurol 61:562-573.
125. CIP1 in glial progenitor cells. J Neurosci 19:5380-5392.
126. Glass HC, Bonifacio SL, Chau V, Glidden D, Poskitt K, Barkovich AJ, Ferriero DM, Miller SP. 2008a. Recurrent postnatal infections are associated with progressive white matter injury in premature infants. Pediatrics 122:299-305.
127. Glass HC, Fujimoto S, Ceppi-Cozzio C, Bartha AI, Vigneron DB, Barkovich AJ, Glidden DV, Ferriero DM, Miller SP. 2008b. White-matter injury is associated with impaired gaze in premature infants. Pediatr Neurol 38:10-15.
128. Goldman SA, Schanz S, Windrem MS. 2008. Stem cell-based strategies for treating pediatric disorders of myelin. Hum Mol Genet 17:R76-R83.
129. Gray PH, Burns YR, Mohay HA, O'Callaghan MJ, Tudehope DI. 1995. Neurodevelopmental outcome of preterm infants with bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 73:F128-F134.
130. Gressens P, Schwendimann L, Husson I, Sarkozy G, Mocaer E, Vamecq J, Spedding M. 2008. Agomelatine, a melatonin receptor agonist with 5-HT(2C) receptor antagonist properties, protects the developing murine white matter against excitotoxicity. Eur J Pharmacol 588:58-63.
131. Griffith JL, Shimony JS, Cousins SA, Rees SE, McCurnin DC, Inder TE, Neil JJ. 2012. MR imaging correlates of white-matter pathology in a preterm baboon model. Pediatr Res 71:185-191.
132. Guan J, Bennet L, George S, Wu D, Waldvogel HJ, Gluckman PD, Faull RLM, Crosier PS, Gunn AJ. 2001. Insulin-like growth factor-1 reduces postischemic white matter injury in fetal sheep. J Cereb Blood Flow Metab 21:493-502.
133. Gunn AJ, Bennet L. 2008. Brain cooling for preterm infants. Clin Perinatal 35:735-748.
134. Gunn AJ, Bennet L. 2009. Fetal hypoxia insults and patterns of brain injury: Insights from animal models. Clin Perinatol 36:579-593.
135. Gupta N, Henry RG, Strober J, Kang SM, Lim DA, Bucci M, Caverzasi E, Gaetano L, Mandelli ML, Ryan T, Perry R, Farrell J, Jeremy RJ, Ulman M, Huhn SL, Barkovich AJ, Rowitch DH. 2012. Neural stem cell engraftment and myelination in the human brain. Sci Transl Med 4:155ra137.
136. Hack M, Taylor H, Drotar D, Schluchter M, Cartar L, Andreias L, Wilson-Costello D, Klein N. 2005. Chronic conditions, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990's. JAMA 294:318-325.
137. Hagberg H, Peebles D, Mallard C. 2002. Models of white matter injury: Comparison of infectious, hypoxic-ischemic, and excitotoxic insults. MRDD Res Rev 8:30-38.
138. Han B, D'Costa A, Back SA, Parsadian M, Patel S, Shah A, Gidday J, Srinvasan A, Deshmukh M, Holtzman D. 2000. BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia. Neurobiol Dis 7:38-53.
139. Haynes RL, Billiards SS, Borenstein NS, Volpe JJ, Kinney HC. 2008. Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin. Pediatr Res 63:656-661.
140. Haynes RL, van Leyen K. 2013. 12/15-lipoxygenase expression is increased in oligodendrocytes and microglia of periventricular leukomalacia. Dev Neurosci 35:140-154.
141. He LF, Chen HJ, Qian LH, Chen GY, Buzby JS. 2010. Curcumin protects pre-oligodendrocytes from activated microglia in vitro and in vivo. Brain Res 1339:60-69.
142. Henderson J, Reynolds J, Dexter F, Atkins B, Hrdy J, Poduska D, Penning D. 1998. Chronic hypoxemia causes extracellular glutamate concentration to increase in the cerebral cortex of the near-term fetal sheep. Dev Brain Res 105:287-293.
143. Hirayama A, Okoshi Y, Hachiya Y, Ozawa Y, Ito M, Kida Y, Imai Y, Kohsaka S, Takashima S. 2001. Early immunohistochemical detection of axonal damage and glial activation in extremely immature brains with periventricular leukomalacia. Clin Neuropathol 20:87-91.
144. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, Yuan J. 2008. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135:1311-1323.
145. Ho Y, Samarasinghe R, Knoch ME, Lewis M, Aizenman E, DeFranco DB. 2008. Selective inhibition of mitogen-activated protein kinase phosphatases by zinc accounts for extracellular signal-regulated kinase 1/2-dependent oxidative neuronal cell death. Mol Pharmacol 74:1141-1151.
146. Huppi PS, Murphy B, Maier SE, Zientara GP, Inder TE, Barnes PD, Kikinis R, Jolesz FA, Volpe JJ. 2001. Microstructural brain development after perinatal cerebral white matter injury assessed by diffusion tensor magnetic resonance imaging. Pediatrics 107:455-460.
147. Husson I, Mesples B, Bac P, Vamecq J, Evrard P, Gressens P. 2002. Melatonergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 51:82-92.
148. Hutton LC, Castillo-Melendez M, Smythe GA, Walker DW. 2008. Microglial activation, macrophage infiltration, and evidence of cell death in the fetal brain after uteroplacental administration of lipopolysaccharide in sheep in late gestation. Am J Obstet Gynecol 198:117 e1-e11.
149. Iida K, Takashima S, Ueda K. 1995. Immunohistochemical study of myelination and oligodendrocyte in infants with periventricular leukomalacia. Pediatr Neurol 13:296-304.
150. Ikeda T, Choi BH, Yee S, Murata Y, Quilligan EJ. 1999. Oxidative stress, brain white matter damage and intrauterine asphyxia in fetal lambs. Int J Dev Neurosci 17:1-14.
151. Inder T, Mocatta T, Darlow B, Spencer C, Volpe JJ, Winterbourn C. 2002. Elevated free radical products in the cerebrospinal fluid of VLBW infants with cerebral white matter injury. Pediatr Res 52:213-218.
152. Ireland Z, Dickinson H, Fleiss B, Hutton LC, Walker DW. 2010. Behavioural effects of near-term acute fetal hypoxia in a small precocial animal, the spiny mouse (Acomys cahirinus). Neonatology 97:45-51.
153. Itoh T, Beesley J, Itoh A, Cohen AS, Kavanaugh B, Coulter DA, Grinspan JB, Pleasure D. 2002. AMPA glutamate receptor-mediated calcium signaling is transiently enhanced during development of oligodendrocytes. J Neurochem 81:390-402.
154. Ivkovic S, Canoll P, Goldman JE. 2008. Constitutive EGFR signaling in oligodendrocyte progenitors leads to diffuse hyperplasia in postnatal white matter. J Neurosci 28:914-922.
155. Iwamoto HS, Kaufman T, Keil LC, Rudolph AM. 1989. Responses to acute hypoxemia in fetal sheep at 0.6-0.7 gestation. Am J Physiol 256:H613-H620.
156. Jablonska B, Scafidi J, Aguirre A, Vaccarino F, Nguyen V, Borok E, Horvath TL, Rowitch DH, Gallo V. 2012. Oligodendrocyte regeneration after neonatal hypoxia requires FoxO1-mediated p27Kip1 expression. J Neurosci 32:14775-14793.
157. Jacobson LK, Dutton GN. 2000. Periventricular leukomalacia: An important cause of visual and ocular motility dysfunction in children. Surv Ophthalmol 45:1-13.
158. Jakovcevski I, Filipovic R, Mo Z, Rakic S, Zecevic N. 2009. Oligodendrocyte development and the onset of myelination in the human fetal brain. Front Neuroanat 3:5.
159. Jakovcevski I, Zecevic N. 2005. Sequence of oligodendrocyte development in the human fetal telencephalon. Glia 49:480-491.
160. Jantzie LL, Talos DM, Jackson MC, Park HK, Graham DA, Lechpammer M, Folkerth RD, Volpe JJ, Jensen FE. 2013. Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain. Cereb Cortex. 2013 Sep 17 [Epub ahead of print].
161. Jensen AA, Erichsen MN, Nielsen CW, Stensbol TB, Kehler J, Bunch L. 2009. Discovery of the first selective inhibitor of excitatory amino acid transporter subtype 1. J Med Chem 52:912-915.
162. Jin G, Arai K, Murata Y, Wang S, Stins MF, Lo EH, van Leyen K. 2008. Protecting against cerebrovascular injury: Contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia. Stroke 39:2538-2543.
163. John G, Shankar S, Shafit-Zagardo B, Massimi A, Lee S, Raine C, Brosnan C. 2002. Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 8:1115-1121.
164. Juul S. 2012. Neuroprotective role of erythropoietin in neonates. J Matern Fetal Neonatal Med 25:105-107.
165. Kalivas PW. 2009. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10:561-572.
166. Kanaan A, Farahani R, Douglas RM, LaManna JC, Haddad GG. 2006. Effect of chronic continuous or intermittent hypoxia and reoxygenation on cerebral capillary density and myelination. Am J Physiol Regul Integr Comp Physiol 290:R1105-R1114.
167. Kannan S, Dai H, Navath RS, Balakrishnan B, Jyoti A, Janisse J, Romero R, Kannan RM. 2012. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med 4:130ra46.
168. Karadottir R, Cavelier P, Bergersen L, Attwell D. 2005. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438:1162-1166.
169. Katsuki H, Okuda S. 1995. Arachidonic acid as a neurotoxic and neurotrophic substance. Prog Neurobiol 46:607-636.
170. Kaukola T, Herva R, Perhomaa M, Paakko E, Kingsmore S, Vainionpaa L, Hallman M. 2006. Population cohort associating chorioamnionitis, cord inflammatory cytokines and neurologic outcome in very preterm, extremely low birth weight infants. Pediatr Res 59:478-483.
171. Kaur C, Ling EA. 2009. Periventricular white matter damage in the hypoxic neonatal brain: Role of microglial cells. Prog Neurobiol 87:264-280.
172. Kesler SR, Reiss AL, Vohr B, Watson C, Schneider KC, Katz KH, Maller-Kesselman J, Silbereis J, Constable RT, Makuch RW, Ment LR. 2008. Brain volume reductions within multiple cognitive systems in male preterm children at age twelve. J Pediatr 152:513-520, 520 e1.
173. Kim S, Dayani L, Rosenberg PA, Li J. 2010. RIP1 kinase mediates arachidonic acid-induced oxidative death of oligodendrocyte precursors. Int J Physiol Pathophysiol Pharmacol 2:137-147.
174. Kim S, Steelman AJ, Koito H, Li J. 2011. Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors. J Neurochem 116:53-66.
175. Kinney H, Back S. 1998. Human oligodendroglial development: Relationship to periventricular leukomalacia. Semin Pediatr Neurol 5:180-189.
176. Kinney HC, Panigraphy A, Newburger J, Jonas R, Sleeper L. 2005. Hypoxic-ischemic brain injury in infants with congenital heart disease dying after cardiac surgery. Act Neuropathol (Berl) 110:563-578.
177. Knutson P, Ghiani CA, Zhou JM, Gallo V, McBain CJ. 1997. K+ channel expression and cell proliferation are regulated by intracellular sodium and membrane depolarization in oligodendrocyte progenitor cells. J Neurosci 17:2669-2682.
178. Koch J, Miles D, Gilley J, Yang C, Kernie S. 2008. Brief exposure to hyperoxia depletes the glial progenitor pool and impairs functional recovery after hypoxic-ischemic brain injury. J Cereb Blood Flow Metab 28:1294-1306.
179. Kotter MR, Stadelmann C, Hartung HP. 2011. Enhancing remyelination in disease--can we wrap it up? Brain 134:1882-1900.
180. Kriegler S, Chiu S. 1993. Calcium signaling of glial cells along the mammalian axons. J Neurosci 13:4229-4245.
181. Lasry O, Shevell MI, Dagenais L. 2010. Cross-sectional comparison of periventricular leukomalacia in preterm and term children. Neurology 74:1386-1391.
182. Lee A, Lingwood BE, Bjorkman ST, Miller SM, Poronnik P, Barnett NL, Colditz P, Pow DV. 2010. Rapid loss of glutamine synthetase from astrocytes in response to hypoxia: Implications for excitotoxicity. J Chem Neuroanat 39:211-220.
183. Lee Y, Morrison B, Li Y, Lengacher S, Farah M, Hoffman P, Liu Y, Tsinalia A, Jin L, Zhang P-W, et al. 2012. Oligodendrolia metabolically support axons and contribute to neurodegeneration. Nature 487:443-448.
184. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, Rosenberg PA, Volpe JJ, Vartanian T. 2002. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 22:2478-2486.
185. Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M, et al. 2013. The cystine/glutamate antiporter system x(c)(-) in health and disease: From molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal 18:522-555.
186. Li AM, Chau V, Poskitt KJ, Sargent MA, Lupton BA, Hill A, Roland E, Miller SP. 2009. White matter injury in term newborns with neonatal encephalopathy. Pediatr Res 65:85-89.
187. Li J, Baud O, Vartanian T, Volpe J, Rosenberg PA. 2005. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci USA 102:9936-9941.
188. Li J, Ramenaden ER, Peng J, Koito H, Volpe JJ, Rosenberg PA. 2008. Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J Neurosci 28:5321-5330.
189. Li YH, Maher P, Schubert D. 1997. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19:453-463.
190. Licht DJ, Shera DM, Clancy RR, Wernovsky G, Montenegro LM, Nicolson SC, Zimmerman RA, Spray TL, Gaynor JW, Vossough A. 2009. Brain maturation is delayed in infants with complex congenital heart defects. J Thorac Cardiovasc Surg 137:529-536; discussion 536-537.
191. Limperopoulos C, Tworetzky W, McElhinney DB, Newburger JW, Brown DW, Robertson RL Jr, Guizard N, McGrath E, Geva J, Annese D, Dunbar-Masterson C, Trainor B, Laussen PC, du Plessis AJ. 2010. Brain volume and metabolism in fetuses with congenital heart disease: Evaluation with quantitative magnetic resonance imaging and spectroscopy. Circulation 121:26-33.
192. Lin CY, Chang YC, Wang ST, Lee TY, Lin CF, Huang CC. 2010. Altered inflammatory responses in preterm children with cerebral palsy. Ann Neurol 68:204-212.
193. Lin S, Rhodes P, Lei M, Zhang F, Cai Z. 2004. α-Phenyl-n-tert-butyl-nitrone attenuates hypoxic-ischemic white matter injury in the neonatal rat brain. Brain Res 1007:132-141.
194. Lipton SA, Rosenberg PA. 1994. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330:613-622.
195. Litt J, Taylor H, Klein N, Hack M. 2005. Learning disabilities in children with very low birthweight:prevalence, neuropsychological correlates and educational interventions. J Learn Disabil 8:130-141.
196. Liu J, Li J, Qin GL, Chen YH, Wang Q. 2008. Periventricular leukomalacia in premature infants in mainland China. Am J Perinatol 25:535-40.
197. Liu YY, Silverstein FS, Skoff R, Barks JD. 2002. Hypoxic-ischemic oligodendroglial injury in neonatal rat brain. Pediatr Res 51:25-33.
198. Loeliger M, Inder T, Cain S, Ramesh RC, Camm E, Thomson MA, Coalson J, Rees SM. 2006. Cerebral outcomes in a preterm baboon model of early versus delayed nasal continuous positive airway pressure. Pediatrics 118:1640-1653.
199. Loeliger M, Watson CS, Reynolds JD, Penning DH, Harding R, Bocking AD, Rees SM. 2003. Extracellular glutamate levels and neuropathology in cerebral white matter following repeated umbilical cord occlusion in the near term fetal sheep. Neuroscience 116:705-714.
200. Mallard E, Rees S, Stringer M, Cock M, Harding R. 1998. Effects of chronic placental insufficiency on brain development in fetal sheep. Pediatr Res 43:262-270.
201. Manning S, Talos D, Zhou C, Selip D, Park H, Park C, Volpe J, Jensen F. 2008. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci 25:6670-6678.
202. Marin-Padilla M. 1997. Developmental neuropathology and impact of perinatal brain damage. II: White matter lesions of the neocortex. J Neuropathol Exp Neurol 56:219-235.
203. Marret S, Mukendi R, Gadisseux J-F, Gressens P, Evrard P. 1995. Effect of ibotenate on brain development: An excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol 54:358-370.
204. Martinez-Biarge M, Bregant T, Wusthoff CJ, Chew AT, Diez-Sebastian J, Rutherford MA, Cowan FM. 2012. White matter and cortical injury in hypoxic-ischemic encephalopathy: Antecedent factors and 2-year outcome. J Pediatr 161:799-807.
205. McClain CR, Sim FJ, Goldman SA. 2012. Pleiotrophin suppression of receptor protein tyrosine phosphatase-beta/zeta maintains the self-renewal competence of fetal human oligodendrocyte progenitor cells. J Neurosci 32:15066-15075.
206. McClendon E, Chen K, Gong X, Sharifnia E, Hagen M, Cai V, Shaver DC, Riddle A, Dean JM, Gunn AJ, Mohr C, Kaplan JS, Rossi DJ, Kroenke CD, Hohimer AR, Back SA. 2014. Prenatal cerebral ischemia triggers dysmaturation of caudate projection neurons. Ann Neurol 75:508-524.
207. McDonald JW, Althomsons S, Hyrc K, Choi D, Goldberg M. 1998. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 4:291-297.
208. McLaurin J, D'Souza S, Stewart J, Blain M, Beaudet A, Nalbantoglu J, Antel JP. 1995. Effect of tumor necrosis factor alpha and beta on human oligodendrocytes and neurons in culture. Int J Dev Neurosci 13:369-381.
209. McQuillen P, Miller S. 2010. Congenital heart disease and brain development. Ann N Y Acad Sci 1184:68-86.
210. Ment L, Schwartz M, Makuch R, Stewart W. 1998. Association of chronic sublethal hypoxia with ventriculomegaly in the developing rat brain. Brain Res Dev Brain Res 111:197-203.
211. Ment LR, Hirtz D, Huppi PS. 2009. Imaging biomarkers of outcome in the developing preterm brain. Lancet Neurol 8:1042-1055.
212. Mercier CE, Dunn MS, Ferrelli KR, Howard DB, Soll RF. 2010. Neurodevelopmental outcome of extremely low birth weight infants from the Vermont Oxford network: 1998-2003. Neonatology 97:329-338.
213. Merrill JE. 1991. Effects of interleukin-1 and tumor necrosis factor-α on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. Dev Neurosci 13:130-137.
214. Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, Woulfe J, Yin X, Trapp B, McRory J, Rehak R, Zamponi GW, Wang W, Stys PK. 2006. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 439:988-992.
215. Miller DA, Granger WM. 1982 A block diagram, graphical and microcomputer analysis of the O2 transport system. Physiologist 25:111-117.
216. Miller SL, Yan EB, Castillo-Melendez M, Jenkin G, Walker DW. 2005a. Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion. Dev Neurosci 27:200-210.
217. Miller SP, Ferriero D. 2009. From selective vulnerability to connectivity: Insights from newborn brain imaging. Trends Neurosci 32:496-505.
218. Miller SP, Ferriero DM, Leonard C, Piecuch R, Glidden D, Partridge JC, Perez M, Mukherjee P, Vigneron D, Barkovich AJ. 2005b. Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse neurodevelopmental outcome. J Pediatr 147:609-616.
219. Miller SP, McQuillen P, Hamrick S, Xu D, Glidden D, Charlton N, Karl T, Azakie A, Ferriero D, Barkovich A, et al. 2007. Abnormal brain development in newborns with congenital heart disease. N Engl J Med 357:1971-1973.
220. Miller SP, Vigneron D, Henry R, Bohland M, Ceppi-Cozzio C, Hoffman C, Newton N, Partridge JC, Ferriero DM, Barkovich AJ. 2002. Serial quantitative diffusion tensor MRI of the premature brain: Development in newborns with and without injury. J Magn Reson Imaging 16:621-632.
221. Miller SP. 2007. Newborn brain injury: Looking back to the fetus. Ann Neurol 61:285-287.
222. Ming X, Chew LJ, Gallo V. 2013. Transgenic overexpression of sox17 promotes oligodendrocyte development and attenuates demyelination. J Neurosci 33:12528-12542.
223. Moll NM, Hong E, Fauveau M, Naruse M, Kerninon C, Tepavcevic V, Klopstein A, Seilhean D, Chew LJ, Gallo V, Oumesmar BN. 2013. SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis. Glia 61:1659-1672.
224. Mronga T, Stahnke T, Goldbaum O, Richter-Landsberg C. 2004. Mitochondrial pathway is involved in hydrogen-peroxide-induced apoptotic cell death of oligodendrocytes. Glia 46:446-455.
225. Murphy T, Miyamoto M, Sastre A, Schnaar R, Coyle J. 1989a. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2:1547-1558.
226. Murphy T, Parikh A, Schnaar R, Coyle JT. 1989b. Arachidonic acid metabolism in glutamate neurotoxicity. Ann N Y Acad Sci 559:474-477.
227. Ness JK, Romanko MJ, Rothstein RP, Wood TL, Levison SW. 2001. Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors. Dev Neurosci 23:203-208.
228. Northington FJ, Chavez-Valdez R, Graham EM, Razdan S, Gauda EB, Martin LJ. 2011. Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 31:178-189.
229. Ohyu J, Marumo G, Ozawa H, Takashima S, Nakajima K, Kohsaka S, Hamai Y, Machida Y, Kobayashi K, Ryo E, Baba K, Kozuma S, Okai T, Taketani Y. 1999. Early axonal and glial pathology in fetal sheep brains with leukomalacia induced by repeated umbilical cord occlusion. Brain Dev 21:248-252.
230. Oka A, Belliveau MJ, Rosenberg PA, Volpe JJ. 1993. Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention. J Neurosci 13:1441-1453.
231. Olivier P, Baud O, Bouslama M, Evrard P, Gressens P, Verney C. 2007. Moderate growth restriction: Deleterious and protective effects on white matter damage. Neurobiol Dis 26:253-263.
232. Olivier P, Baud O, Evrard P, Gressens P, Verney C. 2005. Prenatal ischemia and white matter damage in rats. J Neuropathol Exp Neurol 64:998-1006.
233. Olivier P, Loron G, Fontaine RH, Pansiot J, Dalous J, Thi HP, Charriaut-Marlangue C, Thomas JL, Mercier JC, Gressens P, Baud O. 2010. Nitric oxide plays a key role in myelination in the developing brain. J Neuropathol Exp Neurol 69:828-837.
234. Ong WY, Leong SK, Garey LJ, Reynolds R. 1996. A light- and electron- microscopic study of GluR4-positive cells in cerebral cortex, subcortical white matter and corpus callosum of neonatal, immature and adult rats. Exp Brain Res 110:367-378.
235. Pagliano E, Fedrizzi E, Erbetta A, Bulgheroni S, Solari A, Bono R, Fazzi E, Andreucci E, Riva D. 2007. Cognitive profiles and visuoperceptual abilities in preterm and term spastic diplegic children with periventricular leukomalacia. J Child Neurol 22:282-288.
236. Paintlia MK, Paintlia AS, Barbosa E, Singh I, Singh AK. 2004. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res 78:347-361.
237. Paintlia MK, Paintlia AS, Contreras MA, Singh I, Singh AK. 2008. Lipopolysaccharide-induced peroxisomal dysfunction exacerbates cerebral white matter injury: Attenuation by N-acetyl cysteine. Exp Neurol 210:560-576.
238. Pallast S, Arai K, Pekcec A, Yigitkanli K, Yu Z, Wang X, Lo EH, van Leyen K. 2010. Increased nuclear apoptosis-inducing factor after transient focal ischemia: A 12/15-lipoxygenase-dependent organelle damage pathway. J Cereb Blood Flow Metab 30:1157-1167.
239. Pallast S, Arai K, Wang X, Lo EH, van Leyen K. 2009. 12/15-Lipoxygenase targets neuronal mitochondria under oxidative stress. J Neurochem 111:882-889.
240. Pang Y, Cai Z, Rhodes P. 2000. Effects of lipopolysaccharide on oligodendrocyte progenitor cells are mediated by astrocytes and microglia. J Neurosci Res 62:510-520.
241. Pang Y, Campbell L, Zheng B, Fan L, Cai Z, Rhodes P. 2010a. Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience 166:464-475.
242. Pang Y, Zheng B, Campbell LR, Fan LW, Cai Z, Rhodes PG. 2010b. IGF-1 can either protect against or increase LPS-induced damage in the developing rat brain. Pediatr Res 67:579-584.
243. Patrizi S, Lachance C, Volpe JJ, Follett P, Jensen FE, Rosenberg PA, Vartanian TK. 2000. Developing oligodendrocytes are selectivity vulnerable to lipopolysaccharides (LPS) toxicity. Pediatr Res 47:464A.
244. Pekcec A, Yigitkanli K, Jung JE, Pallast S, Xing C, Antipenko A, Minchenko M, Nikolov DB, Holman TR, Lo EH, van Leyen K. 2012. Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signaling. FASEB J 27:437-445.
245. Penning D, Grafe J, Hammond R, Matsuda Y, Patrick J, Richardson B. 1994. Neuropathology of the near-term and midgestation ovine fetal brain after sustained in utero hypoxemia. Am J Obstet Gynecol 170:1425-1432.
246. Penninga L, Longo L. 1998. Ovine placentome morphology: Effect of high altitude, long-term hypoxia. Placenta 19:187-193.
247. Perrone S, Negro S, Tataranno ML, Buonocore G. 2010. Oxidative stress and antioxidant strategies in newborns. J Matern Fetal Neonatal Med 23(Suppl 3):63-65.
248. Peterson BS, Vohr B, Staib LH, Cannistraci CJ, Dolberg A, Schneider KC, Katz KH, Westerveld M, Sparrow S, Anderson AW, Duncan CC, Makuch RW, Gore JC, Ment LR. 2000. Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA 284:1939-1947.
249. Petersson KH, Pinar H, Stopa EG, Faris RA, Sadowska GB, Hanumara RC, Stonestreet BS. 2002. White matter injury after cerebral ischemia in ovine fetuses. Pediatr Res 51:768-776.
250. Pierson CR, Folkerth RD, Billiards SS, Trachtenberg FL, Drinkwater ME, Volpe JJ, Kinney HC. 2007. Gray matter injury associated with periventricular leukomalacia in the premature infant. Acta Neuropathol 114:619-631.
251. Preston M, Gong X, Su W, Matsumoto SG, Banine F, Winkler C, Foster S, Xing R, Struve J, Dean J, Baggenstoss B, Weigel PH, Montine TJ, Back SA, Sherman LS. 2013. Digestion products of the PH20 hyaluronidase inhibit remyelination. Ann Neurol 73:266-280.
252. Raad RA, Tan WK, Bennet L, Gunn AJ, Davis SL, Gluckman PD, Johnston BM, Williams CE. 1999. Role of the cerebrovascular and metabolic responses in the delayed phases of injury after transient cerebral ischemia in fetal sheep. Stroke 30:2735-2741.
253. Rakic S, Zecevic N. 2003. Early oligodendrocyte precursor cells in the human fetal telencephalon. Glia 41:117-127.
254. Raymond M, Li P, Mangin JM, Huntsman M, Gallo V. 2011. Chronic perinatal hypoxia reduces glutamate-aspartate transporter function in astrocytes through the Janus kinase/signal transducer and activator of transcription pathway. J Neurosci 31:17864-17871.
255. Rees S, Breen S, Loeliger M, McCrabb G, Harding R. 1999. Hypoxemia near mid-gestation has long-term effects on fetal brain development. J Neuropathol Exp Neurol 58:932-945.
256. Rees S, Hale N, De Matteo R, Cardamone L, Tolcos M, Loeliger M, Mackintosh A, Shields A, Probyn M, Greenwood D, Harding R. 2010. Erythropoietin is neuroprotective in a preterm ovine model of endotoxin-induced brain injury. J Neuropathol Exp Neurol 69:306-319.
257. Rees S, Stringer M, Just Y, Hooper S, Harding R. 1997. The vulnerability of the fetal sheep brain to hypoxemia at mid-gestation. Dev Brain Res 103:103-118.
258. Richardson BS, Carmichael L, Homan J, Patrick JE. 1993. Cerebral oxidative-metabolism in fetal sheep with prolonged and graded hypoxemia. J Dev Physiol 19:77-83.
259. Riddle A, Dean J, JR B, Gong X, Maire J, Chen K, Ahmad T, Chen V, Nguyen T, Kroenke C, Hohimer AR, Back SA. 2011. Histopathological correlates of MRI-defined chronic perinatal white matter injury Ann Neurol 70:493-507.
260. Riddle A, Luo N, Manese M, Beardsley D, Green L, Rorvik D, Kelly K, Barlow C, Kelly J, Hohimer A, Back SA. 2006. Spatial heterogeneity in oligodendrocyte lineage maturation and not cerebral blood flow predicts fetal ovine periventricular white matter injury. J Neurosci 26:3045-3055.
261. Riddle A, Maire J, Cai V, Nguyen T, Gong X, Hansen K, Grafe M, Hohimer A, Back S. 2013. Hemodynamic and metabolic correlates of perinatal white matter injury severity. PLoS One 8:e82940.
262. Riddle A, Maire J, Gong X, Chen K, CD K, AR H, SA B. 2012. Differential susceptibility to axonopathy in necrotic and non-necrotic perinatal white matter injury. Stroke 43:178-184.
263. Robertson NJ, Tan S, Groenendaal F, van Bel F, Juul SE, Bennet L, Derrick M, Back SA, Valdez RC, Northington F, Gunn AJ, Mallard C. 2012. Which neuroprotective agents are ready for bench to bedside translation in the newborn infant? J Pediatr 160:544-552 e4.
264. Rosenberg PA, Dai WM, Gan XD, Ali S, Fu J, Back SA, Sanchez RM, Segal MM, Follett PL, Jensen FE, Volpe JJ. 2003. Mature myelin basic protein-expressing oligodendrocytes are insensitive to kainate toxicity. J Neurosci Res 71:237-245.
265. Sadowska GB, Threlkeld SW, Flangini A, Sharma S, Stonestreet BS. 2012. Ontogeny and the effects of in utero brain ischemia on interleukin-1β and interleukin-6 protein expression in ovine cerebral cortex and white matter. Int J Dev Neurosci 30:457-463.
266. Salter M, Fern R. 2005. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438:1167-1171.
267. Salter MG, Fern R. 2008. The mechanisms of acute ischemic injury in the cell processes of developing white matter astrocytes. J Cereb Blood Flow Metab 28:588-601.
268. Sanchez-Gomez M, Alberdi E, Ibarretxe G, Torre I, Matute C. 2003. Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors. J Neurosci 23:9519-9528.
269. Sanchez-Gomez M, Alberdi E, Perez-Navarro E, Alberch J, Matute C. 2011. Bax and calpain mediate excitotoxic oligodendrocyte death induced via activation of both AMPA and kainate receptors. J Neurosci 31:2996-3006.
270. Sanchez-Gomez M, Matute C. 2000. AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures. Neurobiol Dis 6:475-485.
271. Sato H, Tamba M, Ishii T, Bannai S. 1999. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem 274:11455-11458.
272. Scafidi J, Fagel DM, Ment LR, Vaccarino FM. 2009. Modeling premature brain injury and recovery. Int J Dev Neurosci 27:863-871.
273. Scafidi J, Hammond TR, Scafidi S, Ritter J, Jablonska B, Roncal M, Szigeti-Buck K, Coman D, Huang Y, McCarter RJ Jr, Hyder F, Horvath TL, Gallo V. 2014. Intranasal epidermal growth factor treatment rescues neonatal brain injury. Nature 506:230-234.
274. Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, Davis PG, Tin W, Moddemann D, Solimano A, Ohlsson A, Barrington KJ, Roberts RS. 2012. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA 307:275-282.
275. Schmitz T, Ritter J, Mueller S, Felderhoff-Mueser U, Chew L-J, Gallo V. 2011. Cellular changes underlying hyperoxia-induced delay of white matter development. J Neurosci 31:4327-4344.
276. See J, Zhang X, Eraydin N, Mun SB, Mamontov P, Golden JA, Grinspan JB. 2004. Oligodendrocyte maturation is inhibited by bone morphogenetic protein. Mol Cell Neurosci 26:481-492.
277. See JM, Grinspan JB. 2009. Sending mixed signals: Bone morphogenetic protein in myelination and demyelination. J Neuropathol Exp Neurol 68:595-604.
278. Segovia K, Mcclure M, Moravec M, Luo N, Wang Y, Gong X, Riddle A, Craig A, Struve J, Sherman L, Back SA. 2008. Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury. Ann Neurol 63:517-526.
279. Seiler A, Schneider M, Forster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Radmark O, Wurst W, Bornkamm GW, Schweizer U, Conrad M. 2008. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab 8:237-248.
280. Selip DB, Jantzie LL, Chang M, Jackson MC, Fitzgerald EC, Boll G, Murphy A, Jensen FE. 2012. Regional differences in susceptibility to hypoxic-ischemic injury in the preterm brain: Exploring the spectrum from white matter loss to selective grey matter injury in a rat model. Neurol Res Int 725184.
281. Selmaj K, Raine CS. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339-346.
282. Sfaello I, Baud O, Arzimanoglou A, Gressens P. 2005. Topiramate prevents excitotoxic damage in the newborn rodent brain. Neurobiol Dis 20:837-848.
283. Shah DK, Doyle LW, Anderson PJ, Bear M, Daley AJ, Hunt RW, Inder TE. 2008. Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. J Pediatr 153:170-175, 175 e1.
284. Shannon C, Salter M, Fern R. 2007. GFP imaging of live astrocytes: Regional differences in the effects of ischaemia upon astrocytes. J Anat 210:684-692.
285. Sherman L, Back S. 2008. A GAG reflex prevents repair of the damaged CNS. Trends Neurosci 31:44-52.
286. Sherwin C, Fern R. 2005. Acute lipopolysaccharide-mediated injury in neonatal white matter glia: Role of TNF-α, IL-β, and calcium. J Immunol 175:155-161.
287. Shin D, Shin JY, McManus MT, Ptacek LJ, Fu YH. 2009. Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann Neurol 66:843-857.
288. Silbereis J, Huang E, Back S, Rowitch D. 2010. Toward improved animal models of neonatal white matter injury associate with cerebral palsy. Dis Model Mech 3:678-688.
289. Sizonenko SV, Bednarek N, Gressens P. 2007. Growth factors and plasticity. Semin Fetal Neonatal Med 12:241-249.
290. Sizonenko SV, Camm EJ, Dayer A, Kiss JZ. 2008. Glial responses to neonatal hypoxic-ischemic injury in the rat cerebral cortex. Int J Dev Neurosci 26:37-45.
291. Sizonenko SV, Kiss JZ, Inder T, Gluckman PD, Williams CE. 2005. Distinctive neuropathologic alterations in the deep layers of the parietal cortex after moderate ischemic-hypoxic injury in the P3 immature rat brain. Pediatr Res 57:865-872.
292. Sizonenko SV, Sirimanne E, Mayall Y, Gluckman PD, Inder T, Williams C. 2003. Selective cortical alteration after hypoxic-ischemic injury in the very immature rat brain. Pediatr Res 54:263-269.
293. Sloane J, Batt C, Ma Y, Harris Z, Trapp B, Vartanian T. 2010. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci USA 107:11555-11560.
294. Soria-Pastor S, Gimenez M, Narberhaus A, Falcon C, Botet F, Bargallo N, Mercader JM, Junque C. 2008. Patterns of cerebral white matter damage and cognitive impairment in adolescents born very preterm. Int J Dev Neurosci 26:647-654.
295. Soria-Pastor S, Padilla N, Zubiaurre-Elorza L, Ibarretxe-Bilbao N, Botet F, Costas-Moragas C, Falcon C, Bargallo N, Mercader JM, Junque C. 2009. Decreased regional brain volume and cognitive impairment in preterm children at low risk. Pediatrics 124:e1161-e1170.
296. Spittle AJ, Boyd RN, Inder TE, Doyle LW. 2009. Predicting motor development in very preterm infants at 12 months' corrected age: The role of qualitative magnetic resonance imaging and general movements assessments. Pediatrics 123:512-517.
297. Spittle AJ, Brown NC, Doyle LW, Boyd RN, Hunt RW, Bear M, Inder TE. 2008. Quality of general movements is related to white matter pathology in very preterm infants. Pediatrics 121:e1184-e1189.
298. Stirling DP, Stys PK. 2010. Mechanisms of axonal injury: Internodal nanocomplexes and calcium deregulation. Trends Mol Med 16:160-170.
299. Struve J, Maher P, Li Y, Kinnery S, Fehlings MG, Kuntz Ct, Sherman LS. 2005. Disruption of the hyaluronan-based extracellular matrix in spinal cord promotes astrocyte proliferation. Glia 52:16-24.
300. Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W, DuHadaway JB, Goossens V, Roelandt R, Van Hauwermeiren F, Libert C, Declercq W, Callewaert N, Prendergast GC, Degterev A, Yuan J, Vandenabeele P. 2012. Necrostatin-1 analogues: Critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis 3:e437.
301. Talos DM, Fishman R, Park H, Folkerth R, Follett P, Volpe J, Jensen F. 2006a. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex. J Comp Neurol 497:42-60.
302. Talos DM, Follett PL, Folkerth RD, Fishman RE, Trachtenberg FL, Volpe JJ, Jensen FE. 2006b. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex. J Comp Neurol 497:61-77.
303. Tawk M, Makoukji J, Belle M, Fonte C, Trousson A, Hawkins T, Li H, Ghandour S, Schumacher M, Massaad C. 2011. Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis. J Neurosci 31:3729-3742.
304. Ting P, Yamaguchi S, Bacher J, Killens R, Myers R. 1983. Hypoxic-ischemic cerebral necrosis in midgestation sheep fetuses: Physiopathological correlations. Exp Neurol 80:227-245.
305. Trollmann R, Gassmann M. 2009. The role of hypoxia-inducible transcription factors in the hypoxic neonatal brain. Brain Dev 31:503-509.
306. Turner C, Seli M, Ment L, Stewart WA, Yan H, Johansson B, Fredholm B, Blackburn M, RIvkees S. 2003. A1 adenosine receptors mediate hypoxia-induced ventriculomegaly. Proc Natl Acad Sci USA 100:11718-11722.
307. Turner C, Yan H, Schwartz M, Othman T, Rivkees S. 2002. A1 adenosine receptor activation induces ventriculomegaly and white matter loss. Neuroreport 13:1199-1204.
308. Uchida N, Chen K, Dohse M, Hansen KD, Dean J, Buser JR, Riddle A, Beardsley DJ, Wan Y, Gong X, Nguyen T, Cummings BJ, Anderson AJ, Tamaki SJ, Tsukamoto A, Weissman IL, Matsumoto SG, Sherman, LS, Kroenke CD, Back SA. 2012. Human neural stem cells induce functional myelination in mice with severe dysmyelination. Sci Transl Med 4:90-100.
309. van Leyen K, Arai K, Jin G, Kenyon V, Gerstner B, Rosenberg PA, Holman TR, Lo EH. 2008. Novel lipoxygenase inhibitors as neuroprotective reagents. J Neurosci Res 86:904-909.
310. van Leyen K, Kim HY, Lee SR, Jin G, Arai K, Lo EH. 2006. Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke 37:3014-3018.
311. Vandenabeele P, Grootjans S, Callewaert N, Takahashi N. 2013. Necrostatin-1 blocks both RIPK1 and IDO: Consequences for the study of cell death in experimental disease models. Cell Death Differ 20:185-187.
312. Vartanian T, Li Y, Zhao M, Stefanson K. 1995. Interferon-γ-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis. Mol Med 1:732-743.
313. Volpe JJ. 2001. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 50:553-562.
314. Volpe JJ. 2008a. Neurology of the newborn. Philadelphia: W.B. Saunders. pp 399-407.
315. Volpe JJ. 2008b. Postnatal sepsis, necrotizing entercolitis, and the critical role of systemic inflammation in white matter injury in premature infants. J Pediatr 153:160-163.
316. Volpe JJ. 2009. Brain injury in premature infants: A complex amalgam of destructive and developmental disturbances. Lancet Neurol 8:110-124.
317. Vose LR, Vinukonda G, Jo S, Miry O, Diamond D, Korumilli R, Arshad A, Zia MT, Hu F, Kayton RJ, et al. 2013. Treatment with thyroxine restores myelination and clinical recovery after intraventricular hemorrhage. J Neurosci 33:17232-17246.
318. Wang H, Li J, Follett PL, Zhang Y, Cotanche DA, Jensen FE, Volpe JJ, Rosenberg PA. 2004. 12-Lipoxygenase plays a key role in cell death caused by glutathione depletion and arachidonic acid in rat oligodendrocytes. Eur J Neurosci 20:2049-2058.
319. Wang X, Hellgren G, Lofqvist C, Li W, Hellstrom A, Hagberg H, Mallard C. 2009. White matter damage after chronic subclinical inflammation in newborn mice. J Child Neurol 24:1171-1178.
320. Wang Y, Cheng X, He Q, Zheng Y, Kim D, Whittemore S, Cao Q. 2011. Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins. J Neurosci 31:6053-6058.
321. Webber DJ, van Blitterswijk M, Chandran S. 2009. Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia. Am J Pathol 175:2332-2342.
322. Welin A-K, Sandberg M, Lindblom A, Arvidsson P, Nilsson U, Kjellmer I, Mallard C. 2005. White matter injury following prolonged free radical formation in the 0.65 gestation fetal sheep brain. Pediatr Res 58:100-105.
323. Welin AK, Svedin P, Lapatto R, Sultan B, Hagberg H, Gressens P, Kjellmer I, Mallard C. 2007. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr Res 61:153-158.
324. Wernovsky G, Shillingford A, Gaynor J. 2005. Central nervous system outcomes in children with complex congenital heart disease. Curr Opin Cardiol 20:94-99.
325. Wilke S, Thomas R, Allcock N, Fern R. 2004. Mechanism of acute ischemic injury of oligodendroglia in early myelinating white matter: The importance of astrocyte injury and glutamate release. J Neuropathol Exp Neurol 68:872-881.
326. Wilson-Costello D, Fridedman H, Minich N, Fanaroff A, Hack M. 2005. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics 115:997-1003.
327. Wong DS, Poskitt KJ, Chau V, Miller SP, Roland E, Hill A, Tam EW. 2013. Brain injury patterns in hypoglycemia in neonatal encephalopathy. AJNR Am J Neuroradiol 34:1456-1461.
328. Wood TL, Loladze V, Altieri S, Gangoli N, Levison SW, Brywe KG, Mallard C, Hagberg H. 2007. Delayed IGF-1 administration rescues oligodendrocyte progenitors from glutamate-induced cell death and hypoxic-ischemic brain damage. Dev Neurosci 29:302-310.
329. Wright J, Zhang G, Yu T-S, Kernie S. 2010. Age-related changes in the oligodendrocyte progenitor pool influence brain remodeling after injury. Dev Neurosci 32:499-509.
330. Xiong T, Qu Y, Mu D, Ferriero D. 2011. Erythropoietin for neonatal brain injury: Opportunity and challenge. Int J Dev Neurosci 29:583-591.
331. Yang Z, Levison SW. 2006. Hypoxia/ischemia expands the regenerative capacity of progenitors in the perinatal subventricular zone. Neuroscience 139:555-564.
332. Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, Hu T, Taketo MM, van Es JH, Clevers H, Hsieh J, Bassel-Duby R, Olson EN, Lu QR. 2009. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat Neurosci 12:829-838.
333. Ye Z, Wyeth M, Baltan-Tekkok S, Ransom B. 2003. Functional hemichannels in astrocytes: A novel mechanism of glutamate release. J Neurosci 23:3588-3596.
334. Yigitkanli K, Pekcec A, Karatas H, Pallast S, Mandeville E, Joshi N, Smirnova N, Gazaryan I, Ratan RR, Witztum JL, Montaner J, Holman TR, Lo EH, van Leyen K. 2012. Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke. Ann Neurol 73:129-135.
335. Yonezawa M, Back SA, Gan XD, Rosenberg PA, Volpe JJ. 1996. Cystine deprivation induces oligodendroglial death: Rescue by free radical scavengers and by a diffusible glial factor. J Neurochem 67:566-573.
336. Yoon BH, Kim CJ, Romero R, Jun JK, Park KH, Choi ST, Chi JG. 1997. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol 177:797-802.
337. Yoon BH, Romero R, Yang SH, Jun JK, Kim I-O, Choi J-H, Syn HC. 1996. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 174:1433-1440.
338. Yoshioka A, Hardy M, Younkin DP, Grinspan J, Stern JL, Pleasure D. 1995. α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J Neurochem 64:2442-2448.
339. Zaidi A, Bessert D, Ong J, Xu H, Barks J, Silverstein F. 2004. New oligodendrocytes are generated after neonatal hypoxic-ischemic brain injury in rodents. Glia 46:380-390.
340. Zhang Y, Aizenman E, DeFranco DB, Rosenberg PA. 2007. Intracellular zinc release, 12-lipoxygenase activation and MAPK dependent neuronal and oligodendroglial death. Mol Med 13:350-355.
341. Zhang Y, Wang H, Li J, Dong L, Xu P, Chen W, Neve RL, Volpe JJ, Rosenberg PA. 2006. Intracellular zinc release and ERK phosphorylation are required upstream of 12-lipoxygenase activation in peroxynitrite toxicity to mature rat oligodendrocytes. J Biol Chem 281:9460-9470.
342. Zhang Y, Wang H, Li J, Jiminez DA, Levitan ES, Aizenman E, Rosenberg PA. 2004. Peroxynitrite induced neuronal apoptosis is mediated by intracellular zinc release and 12-lipoxygenase activation. J Neurosci 24:10616-10627.
343. Zhiheng H, Liu J, Cheung P-Y, Chen C. 2009. Long-term cognitive impairment and myelination deficiency in a rat model of perinatal hypoxic-ischemia brain injury. Brain Res 1301:100-109.